Admission to Trading

In brief · summary, not quotable

Oxford Biomedica PLC has announced the admission to trading of 122,901 ordinary shares of 50p each on the London Stock Exchange's Main Market. These shares were allotted under various employee incentive plans, including the LTIP, DBP, SAYE, and ESOS, between April 24, 2026, and June 11, 2026. Following this admission, the total number of ordinary shares in issue has increased to 121,037,141, and the new shares are confirmed to be fungible with existing shares.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes

In accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R, OXB notifies the market that following shares have been admitted to trading pursuant to their allotment under the OXB Long Term Incentive Plan (LTIP), OXB Deferred Bonus Plan (DBP), OXB Sharesave Scheme (SAYE), OXB Employee Share Option Scheme (ESOS) as follows:

Issuer name:	OXFORD BIOMEDICA PLC
Issuer LEI:	213800S1GVQNXQ15K851
Name, type and ISIN of the shares:	Ordinary shares of 50p each GB00BDFBVT43
Number of further shares admitted to trading covered by the notification:	122,901
Total number of shares admitted to trading (including the new shares):	121,037,141
Date range covered by the notification:	24 April 2026 - 11 June 2026

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.